FindMyRecallSubscribe
Class I: serious health riskTerminated

Celebrate Today RED MAMMOTH capsules Recall

RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI…

Celebrate Today · Brentwood, NY

Risk level
Class I
Reported by FDA
Feb 23, 2022
Recall ID
D-0638-2022
Check your lot numberHow we source this data

Summary

Celebrate Today recalled RED MAMMOTH capsules starting Feb 8, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-0638-2022 on Feb 23, 2022. Reason: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug. Status: Terminated.

Why it was recalled

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Product description

RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.

Lot numbers, UPCs & expiration codes

Lot # DK1027, Exp. 08/01/2023

Where it was sold

Product was distributed nationwide in the USA via Amazon Marketplace

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0638-2022
Classification
Class I
Status
Terminated
Recall initiated
Feb 8, 2022
FDA report date
Feb 23, 2022
Quantity
500 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Celebrate Today

Original FDA data

Every field from FDA enforcement report D-0638-2022, exactly as published.

Show all FDA fields
City
Brentwood
State
NY
Status
Terminated
Country
United States
Event ID
89563
Address
143 Front Ave
Code information
Lot # DK1027, Exp. 08/01/2023
Postal code
11717-5113
Report date
Feb 23, 2022
Product type
Drugs
Recall number
D-0638-2022
Classification
Class I
Recalling firm
Celebrate Today
Product quantity
500 cartons
Termination date
Mar 29, 2022
Reason for recall
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Voluntary / mandated
Voluntary: Firm initiated
Product description
RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.
Distribution pattern
Product was distributed nationwide in the USA via Amazon Marketplace
Recall initiation date
Feb 8, 2022
Initial firm notification
Press Release
Center classification date
Feb 28, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0638-2022, published Feb 23, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls